| EBITDA Margin guidance | 23.0% → 24.0% Raised by 1.0 percentage points |
|---|
| Revenue growth | +40% YoY to ₹576 Cr; incl. ₹19.4 Cr Arena; 5% sequential USD growth. |
|---|---|
| Margins | Pre-R&D margin 35.8% vs 34.1% last year; third straight quarter of expansion. |
| Demand visibility | Strong visibility claimed; no quantified demand outlook given. |
| Management confidence | Upbeat; repeated 'strong visibility' despite fresh inspection observations. |
Growth
Revenue +40% YoY, H1 +45%; Arena adds ₹19.4 Cr; Q1 PAT included ₹3.6 Cr one-off insurance claim.
Outlook
Guides FY27 operating EBITDA margin 24%+ (from 23%+); ₹313 Cr of ₹500 Cr R&D spent, rest expected in three quarters.
Risks
Fresh Ambarnath/Satara observations await EIR; licensing change may lose approvals; 25%+ capital employed is pre-revenue.
Last quarter's promises, checked
Delivered
- Op EBITDA margin 22–23% → 25% (= BEAT)
Partly delivered
- R&D >₹500 Cr over FY26–Q1 FY28 → ₹313 Cr spent, 3 quarters left (= PARTIAL)
- Pithampur ops mid-CY26, commercial Q1 CY27 → no update this call, unverified (= PARTIAL)
Earnings Call Transcript filed with NSE, NSE: RUBICON. Summary written with AI assistance from the document.
Rubicon Research Ltd: key numbers
- Share price
- ₹1,659.30
- Market cap
- ₹27,467 Cr
- Revenue (annual)
- ₹1,754 Cr
- Net profit (annual)
- ₹246.7 Cr
- P/E (TTM)
- 84.5×Sector 43.0×
- Promoter holding
- 51.25%-8.51% QoQ
- FII holding
- 9.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Rubicon Research Ltd
All →Rubicon Research Other Announcement
Rubicon Research filed the India Ratings monitoring agency report for the IPO fresh issue proceeds for the quarter ended September 30, 2026. The agency found no deviation from the stated objects of the issue.
Rubicon Research Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹5,764Mn (+39.9%), EBITDA ₹1,464Mn (+54.1%, 25.4% margin), PAT ₹904Mn (+67.9%). Arinna consolidated; FY27 margin guidance raised to 24%+.
Rubicon Research Q2 FY27 Results: Net Profit ₹90.4 Cr, Up 67.7% YoY
Rubicon Research Ltd reported revenue from operations of ₹576.4 Cr (+39.9% YoY) and net profit of ₹90.4 Cr (+67.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹90.4 Cr · +67.7% YoY
Rubicon Research Employee Stock Options
Rubicon Research Limited granted 68,982 stock options at an exercise price of Rs. 1,374.40 per share. The options vest over five years under the company's 2026 ESOP plan.
Rubicon Research Business Update
Rubicon Research disclosed a USFDA inspection of its Ambernath facility, which issued five procedural Form 483 observations. No monetary penalty or amount is involved.
Rubicon Research Board Meeting Date
Rubicon Research scheduled its Board for November 5, 2026, to consider unaudited financial results for the half year ended September 2026. Trading window closed since October 1.